Search research articles
Contact Us
Filters
Showing results (41-50 of 183) with videos related to
Page
of 19
Sort By:
Leukemia & Lymphoma
|
April 19, 2019
Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naïve patients
Abi Vijenthira, Manjula Maganti, Vishal Kukreti, et al.
Bone Marrow Transplantation
|
December 23, 2017
Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma
Umberto Falcone, Haiyan Jiang, Shaheena Bashir, et al.
Leukemia & Lymphoma
|
October 31, 2014
Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab
Giselle Salmasi, Michael Li, Vithika Sivabalasundaram, et al.
Hematology (Amsterdam, Netherlands)
|
March 9, 2006
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma
John Kuruvilla, Kevin Song, Peter Mollee, et al.
Leukemia & Lymphoma
|
April 2, 2014
A single institution experience of extranodal natural killer/T cell lymphoma of nasal type
Luluel Khan, David Hodgson, Alex Sun, et al.
Leukemia & Lymphoma
|
May 16, 2017
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma
Haowei Linda Sun, Eshetu G Atenafu, Richard Tsang, et al.
Experimental Hematology & Oncology
|
May 5, 2015
Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis
Georg Hess, Bertrand Coiffier, Michael Crump, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 25, 2003
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy
David C Hodgson, Richard W Tsang, Melania Pintilie, et al.
Cancer Cytopathology
|
January 31, 2013
EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples
Mauro Ajaj Saieg, William R Geddie, Scott L Boerner, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 27, 2017
Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 Cases
Abhijat Kitchlu, Warren Fingrut, Carmen Avila-Casado, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 183) with videos related to
Sort By:
Page
of 19
Leukemia & Lymphoma
|
April 19, 2019
Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naïve patients
Abi Vijenthira, Manjula Maganti, Vishal Kukreti, et al.
Bone Marrow Transplantation
|
December 23, 2017
Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma
Umberto Falcone, Haiyan Jiang, Shaheena Bashir, et al.
Leukemia & Lymphoma
|
October 31, 2014
Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab
Giselle Salmasi, Michael Li, Vithika Sivabalasundaram, et al.
Hematology (Amsterdam, Netherlands)
|
March 9, 2006
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma
John Kuruvilla, Kevin Song, Peter Mollee, et al.
Leukemia & Lymphoma
|
April 2, 2014
A single institution experience of extranodal natural killer/T cell lymphoma of nasal type
Luluel Khan, David Hodgson, Alex Sun, et al.
Leukemia & Lymphoma
|
May 16, 2017
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma
Haowei Linda Sun, Eshetu G Atenafu, Richard Tsang, et al.
Experimental Hematology & Oncology
|
May 5, 2015
Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis
Georg Hess, Bertrand Coiffier, Michael Crump, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 25, 2003
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy
David C Hodgson, Richard W Tsang, Melania Pintilie, et al.
Cancer Cytopathology
|
January 31, 2013
EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples
Mauro Ajaj Saieg, William R Geddie, Scott L Boerner, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 27, 2017
Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 Cases
Abhijat Kitchlu, Warren Fingrut, Carmen Avila-Casado, et al.
Page
of 19